期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

他汀类药物与卒中研究进展 被引量：15

Recent Development of the Study about the Relationship between Statins and Stroke
暂未订购
导出
摘要 他汀类药物不但对卒中有一级、二级预防作用,而且可以改善急性缺血性卒中的早期及远期预后。本文就近年来关于他汀类药物与卒中研究的进展做一综述。 Statins can not only reduce the risk of first and recurrent stroke but also improve early and late outcomes in patients with acute ischaemie stroke. This article reviewed the current findings and recent developments in this field.
作者 赖智勇 李光勤 黄浩然 付敏
机构地区 重庆医科大学附属第一医院神经内科
出处 《中国全科医学》 CAS CSCD 北大核心 2012年第8期942-945,共4页 Chinese General Practice
关键词 他汀类药物 卒中 预防 预后 神经保护药 Statins Stroke Prevention Prognosis Neuroprotective agents
分类号 R743 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献7

  • 1Shahar E,Chambless LE,Rosamond WD. Plasma lipid profile and incident ischemic stroke:The Atherosclerosis Risk in Communities(ARIC)study[J].Stroke,2003,(03):623-631.doi:10.1161/01.STR.0000057812.51734.FF.
  • 2Prospective studies collaboration,Lewington S,Whitlock G. Blood cholesterol and vascular mortality by age,sex,and blood pressure:a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths[J].The Lancet,2007,(9602):1829-1839.
  • 3Amarenco P,Labreuche J,Lavallée P. Statins in stroke prevention and carotid atherosclerosis:systematic review and up-to-date meta-analysis[J].Stroke,2004,(12):2902-2909.
  • 4Goldstein LB,Amarenco P,Szarek M. Hemorrhagic stroke in the stroke prevention by aggressive reduction in cholesterol levels study[J].Neurology,2008,(24 Pt 2):2364-2370.doi:10.1212/01.wnl.0000296277.63350.77.
  • 5王艺铮,王拥军.低密度脂蛋白与卒中[J].中国卒中杂志,2009,4(1):67-73. 被引量：6
  • 6陈培豪,高山.缺血性卒中的分型—从原始TOAST到ASCO分型[J].中国卒中杂志,2011,6(5):416-422. 被引量：8
  • 7王拥军.卒中:回眸2009[J].中国卒中杂志,2010,5(1):1-8. 被引量：6

二级参考文献56

  • 1Feigin VL,Lawes CM,Bennett DA,et al.Worldwide stroke incidence and early case fatality reported in 56 population-based studies:a systematic review[J].Lancet Neurol,2009,8:355-869.
  • 2Johnston SC,Mendis S,Mathers CD.Global variation in stroke burden and mortality:estimates from monitoring,surveillance,and modeliing[J].Lancet Neurol,2009,8:345-354.
  • 3Amarenco P,Bogousslavsky J,Caplan LR,et al.Classification of stroke subtypes[J].Cerebrovasc Dis,2009,27:493-501.
  • 4Debette S,Seshadri S.Genetics of atherothrombotic and lacunar stroke[J].Circulation:Cardiovascular Genetics,2009,2:191-198.
  • 5Ikram MA,Seshadri S,Bis JC,et al.Genomewide association studies of stroke[J].N Engl J Med,2009,360:1718-1728.
  • 6Hara K,Shiga A,Fukutake T,et al.Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease[J].N Engl J Med,2009,360:1729-1739.
  • 7Simon T,Verstuyft C,Pharm D,et al.Genetic determinants of response to clopidogrel and cardiovascular events[J].N Engl J Med 2009,360:363-375.
  • 8Mega JL,Close SL,Wiviott SD,et al.Cytochrome P-450 polymorphisms and response to clopidogre[J].N Engl J Med 2009;360:354-362.
  • 9Bluhmki E,Chamorro A,Dávalos A,et al.Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS Ⅲ):additional outcomes and subgroup analysis of a randomised controlled trial[J].Lancet Neurol,2009,8:1095-1102.
  • 10Saver JL,Gornbein J,Grotta J,et al.Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3-to 4.5-hour window[J].Stroke,2009,40:2433-2437.

共引文献16

同被引文献142

引证文献15

二级引证文献82

中国全科医学
2012年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部